Literature DB >> 33552057

Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.

Ahmed M Abu El-Asrar1,2, Mohd Imtiaz Nawaz1, Ajmal Ahmad1, Alexandra De Zutter3, Mohammad Mairaj Siddiquei1, Marfa Blanter3, Eef Allegaert4, Priscilla W Gikandi1, Gert De Hertogh4, Jo Van Damme3, Ghislain Opdenakker5, Sofie Struyf3.   

Abstract

The transmembrane chemokine pathways CXCL16/CXCR6 and CX3CL1/CX3CR1 are strongly implicated in inflammation and angiogenesis. We investigated the involvement of these chemokine pathways and their processing metalloproteinases ADAM10 and ADAM17 in the pathophysiology of proliferative diabetic retinopathy (PDR). Vitreous samples from 32 PDR and 24 non-diabetic patients, epiretinal membranes from 18 patients with PDR, rat retinas, human retinal Müller glial cells and human retinal microvascular endothelial cells (HRMECs) were studied by enzyme-linked immunosorbent assay, immunohistochemistry and Western blot analysis. In vitro angiogenesis assays were performed and the adherence of leukocytes to CXCL16-stimulated HRMECs was assessed. CXCL16, CX3CL1, ADAM10, ADAM17 and vascular endothelial growth factor (VEGF) levels were significantly increased in vitreous samples from PDR patients. The levels of CXCL16 were 417-fold higher than those of CX3CL1 in PDR vitreous samples. Significant positive correlations were found between the levels of VEGF and the levels of CXCL16, CX3CL1, ADAM10 and ADAM17. Significant positive correlations were detected between the numbers of blood vessels expressing CD31, reflecting the angiogenic activity of PDR epiretinal membranes, and the numbers of blood vessels and stromal cells expressing CXCL16, CXCR6, ADAM10 and ADAM17. CXCL16 induced upregulation of phospho-ERK1/2, p65 subunit of NF-κB and VEGF in cultured Müller cells and tumor necrosis factor-α induced upregulation of soluble CXCL16 and ADAM17 in Müller cells. Treatment of HRMECs with CXCL16 resulted in increased expression of intercellular adhesion molecule-1 (ICAM-1) and increased leukocyte adhesion to HRMECs. CXCL16 induced HRMEC proliferation, formation of sprouts from HRMEC spheroids and phosphorylation of ERK1/2. Intravitreal administration of CXCL16 in normal rats induced significant upregulation of the p65 subunit of NF-κB, VEGF and ICAM-1 in the retina. Our findings suggest that the chemokine axis CXCL16/CXCR6 and the processing metalloproteinases ADAM10 and ADAM17 might serve a role in the initiation and progression of PDR.
Copyright © 2021 Abu El-Asrar, Nawaz, Ahmad, De Zutter, Siddiquei, Blanter, Allegaert, Gikandi, De Hertogh, Van Damme, Opdenakker and Struyf.

Entities:  

Keywords:  ADAM10; ADAM17; CX3CL1; CXCL16; chemokines; metalloproteinases; proliferative diabetic retinopathy

Mesh:

Substances:

Year:  2021        PMID: 33552057      PMCID: PMC7854927          DOI: 10.3389/fimmu.2020.601639

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  78 in total

1.  Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.

Authors:  Toshihiro Nanki; Takeshi Shimaoka; Kenji Hayashida; Ken Taniguchi; Shin Yonehara; Nobuyuki Miyasaka
Journal:  Arthritis Rheum       Date:  2005-10

2.  CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

Authors:  Qiang Gao; Ying-Jun Zhao; Xiao-Ying Wang; Shuang-Jian Qiu; Ying-Hong Shi; Jian Sun; Yong Yi; Jie-Yi Shi; Guo-Ming Shi; Zhen-Bin Ding; Yong-Sheng Xiao; Zhong-Hua Zhao; Jian Zhou; Xiang-Huo He; Jia Fan
Journal:  Cancer Res       Date:  2012-06-18       Impact factor: 12.701

3.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.

Authors:  M V Volin; J M Woods; M A Amin; M A Connors; L A Harlow; A E Koch
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 5.  The role of chemokines and their receptors in angiogenesis.

Authors:  Friedemann Kiefer; Arndt F Siekmann
Journal:  Cell Mol Life Sci       Date:  2011-04-09       Impact factor: 9.261

6.  CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.

Authors:  Y Hosokawa; I Hosokawa; K Ozaki; H Nakae; T Matsuo
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

7.  CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.

Authors:  Giorgia Martini; Anna Cabrelle; Fiorella Calabrese; Samuela Carraro; Elisa Scquizzato; Antonella Teramo; Monica Facco; Francesco Zulian; Carlo Agostini
Journal:  Clin Immunol       Date:  2008-08-28       Impact factor: 3.969

8.  Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.

Authors:  Jewon Ryu; Cheol-Whan Lee; Kyung-Hee Hong; Jin-Ae Shin; Sun-Hee Lim; Chan-Sik Park; Jiyeon Shim; Ki Byung Nam; Kee-Joon Choi; You-Ho Kim; Ki Hoon Han
Journal:  Cardiovasc Res       Date:  2007-11-11       Impact factor: 10.787

9.  Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Authors:  D T Shima; A P Adamis; N Ferrara; K T Yeo; T K Yeo; R Allende; J Folkman; P A D'Amore
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

10.  The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.

Authors:  Soeren Abel; Christian Hundhausen; Rolf Mentlein; Alexander Schulte; Theo A Berkhout; Neil Broadway; Dieter Hartmann; Radek Sedlacek; Sebastian Dietrich; Barbara Muetze; Bjoern Schuster; Karl-Josef Kallen; Paul Saftig; Stefan Rose-John; Andreas Ludwig
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  9 in total

Review 1.  Molecules related to diabetic retinopathy in the vitreous and involved pathways.

Authors:  Hua-Qin Xia; Jia-Rui Yang; Ke-Xin Zhang; Rui-Lan Dong; Hao Yuan; Yu-Chen Wang; Hong Zhou; Xue-Min Li
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Identification of Immune-Associated Genes in Diagnosing Aortic Valve Calcification With Metabolic Syndrome by Integrated Bioinformatics Analysis and Machine Learning.

Authors:  Yufei Zhou; Wenxiang Shi; Di Zhao; Shengjue Xiao; Kai Wang; Jing Wang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 3.  Regulations of Retinal Inflammation: Focusing on Müller Glia.

Authors:  Yingying Chen; Qinghong Xia; Yue Zeng; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-27

4.  Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation.

Authors:  Ahmed M Abu El-Asrar; Ajmal Ahmad; Mohd Imtiaz Nawaz; Mohammad Mairaj Siddiquei; Alexandra De Zutter; Lotte Vanbrabant; Priscilla W Gikandi; Ghislain Opdenakker; Sofie Struyf
Journal:  Front Physiol       Date:  2022-01-10       Impact factor: 4.566

5.  PAI-1 is a vascular cell-specific HIF-2-dependent angiogenic factor that promotes retinal neovascularization in diabetic patients.

Authors:  Yaowu Qin; Jing Zhang; Savalan Babapoor-Farrokhran; Brooks Applewhite; Monika Deshpande; Haley Megarity; Miguel Flores-Bellver; Silvia Aparicio-Domingo; Tao Ma; Yuan Rui; Stephany Y Tzeng; Jordan J Green; M Valeria Canto-Soler; Silvia Montaner; Akrit Sodhi
Journal:  Sci Adv       Date:  2022-03-02       Impact factor: 14.957

6.  Redox and Calcium Alterations of a Müller Cell Line Exposed to Diabetic Retinopathy-Like Environment.

Authors:  Clarissa Rosato; Barbara Bettegazzi; Pia Intagliata; Maria Balbontin Arenas; Daniele Zacchetti; Antonella Lanati; Gianpaolo Zerbini; Francesco Bandello; Fabio Grohovaz; Franca Codazzi
Journal:  Front Cell Neurosci       Date:  2022-03-18       Impact factor: 5.505

7.  Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Eef Allegaert; Mohammad Mairaj Siddiquei; Ajmal Ahmad; Priscilla Gikandi; Gert De Hertogh; Ghislain Opdenakker
Journal:  Molecules       Date:  2022-09-14       Impact factor: 4.927

8.  Resveratrol Inhibited ADAM10 Mediated CXCL16-Cleavage and T-Cells Recruitment to Pancreatic β-Cells in Type 1 Diabetes Mellitus in Mice.

Authors:  Mohamed S Abdel-Bakky; Abdulmajeed Alqasoumi; Waleed M Altowayan; Elham Amin; Mostafa A Darwish
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

9.  Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.

Authors:  Ekaterini Simões Goudouris; Fernanda Pinto-Mariz; Leonardo Oliveira Mendonça; Carolina Sanchez Aranda; Rafaela Rolla Guimarães; Cristina Kokron; Myrthes Toledo Barros; Flávia Anísio; Maria Luiza Oliva Alonso; Fernanda Marcelino; Solange Oliveira Rodrigues Valle; Sergio Dortas Junior; Irma Douglas Paes Barreto; Janáira Fernandes Severo Ferreira; Pérsio Roxo-Junior; Almerinda Maria do Rego Silva; Fernanda Lugão Campinhos; Carmem Bonfim; Gisele Loth; Juliana Folloni Fernandes; Julia Lopes Garcia; Albertina Capelo; Olga Akiko Takano; Maria Isabel Valdomir Nadaf; Eliana C Toledo; Luciana Araújo Oliveira Cunha; Regina Sumiko Watanabe Di Gesu; Laire Schidlowski; Priscila Fillipo; Daniélli C Bichuetti-Silva; Gustavo Soldateli; Natasha Rebouças Ferraroni; Ellen de Oliveira Dantas; Simone Pestana; Eli Mansour; Raisa Gusso Ulaf; Carolina Prando; Antonio Condino-Neto; Anete Sevciovic Grumach
Journal:  J Clin Immunol       Date:  2021-06-23       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.